featured
Locoregional Treatment Improves Overall Survival in De Novo Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Surgical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis
Ann. Surg. Oncol 2019 Feb 01;26(2)356-365, E Pons-Tostivint, Y Kirova, A Lusque, M Campone, J Geffrelot, C Mazouni, A Mailliez, D Pasquier, N Madranges, N Firmin, A Crouzet, A Gonçalves, C Jankowski, T De La Motte Rouge, N Pouget, B de La Lande, D Mouttet-Boizat, JM Ferrero, L Uwer, JC Eymard, MA Mouret-Reynier, T Petit, M Robain, T Filleron, C Cailliot, F DalencFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.